IDEAYA Biosciences, Inc. Income Taxes Paid
IDEAYA Biosciences, Inc. (IDYA) reported Income Taxes Paid of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-20.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2024-02-20
- IDEAYA Biosciences, Inc. income taxes paid, net for the quarter ending 2022-12-31 was $0.00.
- IDEAYA Biosciences, Inc. income taxes paid, net for the quarter ending 2022-09-30 was $0.00.
- IDEAYA Biosciences, Inc. income taxes paid, net for the quarter ending 2021-12-31 was $0.00.
- IDEAYA Biosciences, Inc. income taxes paid, net for the quarter ending 2021-09-30 was $0.00.
- IDEAYA Biosciences, Inc. income taxes paid, net for fiscal 2023 was $0.00.
- IDEAYA Biosciences, Inc. income taxes paid, net for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- IDEAYA Biosciences, Inc. income taxes paid, net for fiscal 2021 was $4.00K, a 300.00% increase from fiscal 2020.
- IDEAYA Biosciences, Inc. income taxes paid, net for fiscal 2020 was $1.00K, a 0.00% change from fiscal 2019.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-20 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $0.00 derived: sum of 2 quarters · filed 2024-02-20 | $0.00 10-K · filed 2024-02-20 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $0.00 derived: sum of 2 quarters · filed 2024-02-20 | $4.00K 10-K · filed 2024-02-20 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.00K 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $4.00K 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $0.00 derived: sum of 2 quarters · filed 2023-03-07 | $0.00 derived: sum of 3 quarters · filed 2023-03-07 | $1.00K 10-K · filed 2023-03-07 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $1.00K 10-Q · filed 2021-11-15 | $1.00K derived: sum of 4 quarters · filed 2022-03-18 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $1.00K 10-Q · filed 2021-08-10 | $1.00K derived: sum of 3 quarters · filed 2022-03-18 | $1.00K derived: sum of 4 quarters · filed 2022-03-18 |
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-10 | $1.00K derived: sum of 2 quarters · filed 2022-03-18 | $1.00K derived: sum of 3 quarters · filed 2022-03-18 | $1.00K derived: sum of 4 quarters · filed 2022-03-18 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $0.00 derived: sum of 2 quarters · filed 2022-03-18 | $0.00 derived: sum of 3 quarters · filed 2022-03-18 | $1.00K 10-K · filed 2022-03-18 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $1.00K 10-Q · filed 2020-11-12 | $1.00K derived: sum of 4 quarters · filed 2021-03-23 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $1.00K 10-Q · filed 2020-08-12 | $1.00K derived: sum of 3 quarters · filed 2021-03-23 | $1.00K derived: sum of 4 quarters · filed 2021-03-23 |
| 2019-03-31 | $1.00K 10-Q · filed 2020-05-12 | $1.00K derived: sum of 2 quarters · filed 2021-03-23 | $1.00K derived: sum of 3 quarters · filed 2021-03-23 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $0.00 derived: sum of 2 quarters · filed 2021-03-23 | $1.00K 10-K · filed 2021-03-23 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $1.00K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $1.00K 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |